This page contains brief information about sorafenib tosylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Sorafenib tosylate is approved to treat:
- Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery.
- Renal cell carcinoma (a type of kidney cancer) that is advanced.
- Thyroid cancer in certain patients with progressive, recurrent, or metastatic disease that does not respond to treatment with radioactive iodine.
Sorafenib tosylate is also being studied in the treatment of other types of cancer.
More About Sorafenib Tosylate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Sorafenib Tosylate - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Sunitinib and Sorafenib Ineffective as Adjuvant Therapies for Kidney Cancer - Information from NCI about this drug.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Clinical Trial Results: Sorafenib Improves Progression-Free Survival in Some Patients With Metastatic Thyroid Cancer - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trials Accepting Patients
Find Clinical Trials for Sorafenib Tosylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.